NCT02196909View on ClinicalTrials.gov

Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions

HIBM

Interventions

OTHER

motor function and strength assessment

OTHER

NMR assessment

OTHER

24h urine and serum collection

Trial Locations (1)

75013

Institute of Myology, Paris

All Listed Sponsors

lead

Institut de Myologie, France

OTHER

NCT02196909 - Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE) | Biotech Hunter | Biotech Hunter